Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|January 1, 1988
N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonistsL E Arvidsson, A M Johansson, U Hacksell, et al.The Journal of Pharmacology and Experimental Therapeutics|April 4, 2007
In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonistsR A Bakker, M W Nicholas, T T Smith, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1981
Effects of a new type of 5-HT receptor agonist on male rat sexual behaviorS Ahlenius, K Larsson, L Svensson, et al.Molecular Pharmacology|February 24, 2004
8R-lisuride is a potent stereospecific histamine H1-receptor partial agonistR A Bakker, D M Weiner, T ter Laak, et al.Journal of Neural Transmission. Supplementum|January 1, 1983
The search for selective dopaminergic autoreceptor agonistsS Hjorth, A Carlsson, D Clark, et al.Journal of Medicinal Chemistry|August 1, 1984
Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: central dopamine receptor activityH Wikström, D Sanchez, P Lindberg, et al.Chirality|January 11, 1992
Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brainW S Messer, D O Ngur, Y F Abuh, et al.Chirality|January 1, 1996
Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptorsS E Hillver, L Björk, B B Höök, et al.Journal of Medicinal Chemistry|April 10, 1999
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamineI J De Esch, R C Vollinga, K Goubitz, et al.The Journal of Pharmacology and Experimental Therapeutics|September 2, 2005
Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonistE S Burstein, J Ma, S Wong, et al.Pageof 10